Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T.Y. Kam
P2.01-53 Local Treatment for Oligoprogression/Oligometastases After Failure to Crizotinib for ALK-Rearranged Stage IV Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P121 Clinical Value of Local Therapy in Advanced Crizotinib-Treated ALK-Rearranged Lung Cancer: Pattern of Failure Analyses
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Serial Liquid Biopsies for Detection of Treatment Failure and Profiling of Resistance Mechanisms in KLC1-ALK Rearranged Lung Cancer
Cold Spring Harbor molecular case studies
Biochemistry
Molecular Medicine
Genetics
P1.01-05 Metformin in Combination With Crizotinib for the Treatment of EML4-ALK+ Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-03 Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ASCEND-2: A Canary in a Coal Mine for Descending to Second-Line Treatment for ALK-rearranged Non-Small Cell Lung Cancer
Translational Lung Cancer Research
Oncology
Molecular Mechanisms of Resistance to First- And Second-Generation ALK Inhibitors in ALK-rearranged Lung Cancer
European Journal of Cancer
Cancer Research
Oncology